600078.SH
澄星股份
SSE · Basic Materials · Chemicals · CN
CNY 10.83
+2.36%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.6B | 3.6B | 3.4B | 3.1B | 4.5B |
| Cost of Revenue | 3.1B | 3.2B | 3.1B | 2.8B | 3.5B |
| Gross Profit | 531.7M | 425.0M | 232.9M | 303.2M | 987.7M |
| Operating Expenses | |||||
| R&D Expense | 3.7M | 6.9M | 8.9M | 6.3M | 398.7K |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 213.7M | 205.1M | 189.7M | 166.4M | 168.6M |
| Selling & Marketing Expense | 16.9M | 14.7M | 20.3M | 30.5M | 25.4M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 363.6M | 364.6M | 367.0M | 345.2M | 335.8M |
| Cost and Expenses | 3.5B | 3.5B | 3.5B | 3.1B | 3.9B |
| Operating Income (EBIT) | 261.8M | 152.9M | (117.1M) | 32.4M | 913.9M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 243.4M | 135.5M | (156.3M) | 13.7M | 873.9M |
| Income Tax Expense | 62.0M | 36.7M | (21.5M) | (16.9M) | 93.0M |
| Bottom Line | |||||
| Net Income | 72.0M | 8.5M | (198.9M) | (60.8M) | 521.8M |
| Earnings from Cont. Ops | 181.4M | 98.8M | (134.8M) | 30.5M | 780.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 72.0M | 8.5M | (198.9M) | (60.8M) | 521.8M |
| Per Share | |||||
| Basic EPS | CN¥0.11 | CN¥0.01 | (CN¥0.30) | (CN¥0.09) | CN¥0.79 |
| Diluted EPS | CN¥0.11 | CN¥0.01 | (CN¥0.30) | (CN¥0.09) | CN¥0.79 |
| Revenue Per Share | CN¥5.39 | CN¥4.24 | CN¥5.06 | CN¥4.68 | CN¥6.85 |
| Shares | |||||
| Basic Shares Outstanding | 676.1M | 847.2M | 663.0M | 662.6M | 662.6M |
| Diluted Shares Outstanding | 676.1M | 847.2M | 663.0M | 662.6M | 662.6M |
| Profitability Metrics | |||||
| EBITDA | — | 403.5M | 143.9M | 301.9M | 1.2B |
| D&A | — | 250.6M | 261.0M | 269.4M | 265.2M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026